Hikma Pharmaceuticals (HIK) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Feb 2021 02:55 PM
RNS
Notice of Results
26 Jan 2021 08:01 AM
RNS
Potential Acquisition
15 Jan 2021 03:59 PM
RNS
Hikma provides update on generic Advair Diskus®
13 Jan 2021 09:21 AM
RNS
Director/PDMR Shareholding
13 Jan 2021 09:14 AM
RNS
Director/PDMR Shareholding
18 Dec 2020 10:10 AM
RNS
Holding(s) in Company
17 Dec 2020 05:30 PM
RNS
Hikma launches generic Advair Diskus®
14 Dec 2020 12:57 PM
RNS
Holding(s) in Company
10 Dec 2020 04:00 PM
RNS
Director/PDMR Shareholding
10 Dec 2020 03:51 PM
RNS
Director/PDMR Shareholding
02 Dec 2020 03:00 PM
RNS
Total Voting Rights
02 Dec 2020 01:05 PM
RNS
Holding(s) in Company
09 Nov 2020 11:38 AM
RNS
Holding(s) in Company
05 Nov 2020 11:30 AM
RNS
Directorate Change
05 Nov 2020 07:00 AM
RNS
Hikma launches Icosapent Ethyl Capsules
05 Nov 2020 07:00 AM
RNS
Trading Statement
02 Nov 2020 01:20 PM
RNS
Total Voting Rights
22 Oct 2020 01:16 PM
RNS
Notice to Bondholders
08 Oct 2020 08:38 AM
RNS
Blocklisting Application
01 Oct 2020 11:01 AM
RNS
Block listing Interim Review
22 Sep 2020 07:00 AM
RNS
Hikma updates on ANDA for generic Advair Diskus®
03 Sep 2020 03:15 PM
RNS
Hikma receives favourable court ruling
02 Sep 2020 09:30 AM
RNS
Total Voting Rights
07 Aug 2020 07:00 AM
RNS
Half-year Report
03 Aug 2020 02:25 PM
RNS
Total Voting Rights
16 Jul 2020 12:06 PM
RNS
Notice of Results
07 Jul 2020 12:48 PM
RNS
Publication of Offering Circular
25 Jun 2020 04:12 PM
RNS
Holding(s) in Company
25 Jun 2020 01:00 PM
RNS
Directorate Change
23 Jun 2020 11:39 AM
RNS
Holding(s) in Company
23 Jun 2020 07:00 AM
RNS
Transaction in Own Shares
22 Jun 2020 05:13 PM
RNS
Transaction in Own Shares
22 Jun 2020 11:24 AM
RNS
Director/PDMR Shareholding
22 Jun 2020 11:22 AM
RNS
Director/PDMR Shareholding
22 Jun 2020 11:20 AM
RNS
Director/PDMR Shareholding
02 Jun 2020 09:31 AM
RNS
Total Voting Rights
22 May 2020 07:00 AM
RNS
Hikma receives FDA approval for generic Vascepa®
20 May 2020 03:42 PM
RNS
Director/PDMR Shareholding
13 May 2020 01:28 PM
RNS
Director/PDMR Shareholding
01 May 2020 11:30 AM
RNS
Total Voting Rights
30 Apr 2020 12:00 PM
RNS
Result of AGM
30 Apr 2020 07:00 AM
RNS
Directorate Change
30 Apr 2020 07:00 AM
RNS
Trading Statement
16 Apr 2020 03:07 PM
RNS
Director/PDMR Shareholding
14 Apr 2020 02:30 PM
RNS
Block listing Interim Review
02 Apr 2020 07:00 AM
RNS
AGM Update
31 Mar 2020 07:00 AM
RNS
Hikma's favourable ruling in generic Vascepa®
24 Mar 2020 10:52 AM
RNS
Director/PDMR Shareholding
19 Mar 2020 12:00 PM
RNS
Annual Financial Report
28 Feb 2020 12:27 PM
RNS
Director/PDMR Shareholding

Hikma Pharmaceuticals is a British multinational pharmaceutical company, founded in 1978, that develops, manufactures, and markets a wide range of generic, branded, and in-licensed pharmaceutical products, with a focus on making high-quality medicines accessible.

Hikma share price launched at 281p in 2005.

 

UK 100

Latest directors dealings